Hepatic Encephalopathy
Hepatic Encephalopathy (HE) is a neurological disorder resulting from severe liver disease, wherein the liver's inability to remove toxins from the blood leads to symptoms such as confusion, forgetfulness, personality changes, movement problems, and in advanced stages, coma. The condition can manifest gradually or suddenly, significantly impacting brain function.
Health Outcomes
- Accelerated Recovery in Immunocompromised Mice
- Altered Plasma Metabolite Levels
- Attenuated Hepatic Disorders
- Elevated Acetic Acid Levels
- Elevated Lactate Levels
- Elevated Serum Enzyme Levels
- Improved Alcohol-Associated Liver Disease Parameters
- Improved CST Status to CST I
- Improved Child-Pugh Scores
- Improved Chronic Alcohol-Induced Liver Injury
- Improved Detoxification
- Improved Enzyme Activity
- Improved Enzyme Levels (ADH, ALDH)
- Improved Growth in Bile-Containing Medium
- Improved Hepatic Damage
- Improved Hepatic Disease
- Improved Hepatic Encephalopathy
- Improved Hepatic Oxidative Stress
- Improved Liver Antioxidant Capacity
- Improved Liver Disease Biomarkers
- Improved Liver Enzyme Function
- Improved Liver Function
- Improved Liver Health
- Improved Liver Metabolic Pathways
- Improved Liver Regeneration
- Improved Minimal Hepatic Encephalopathy
- Improved Resistance to Ammonia Nitrogen Stress
- Improved Serum Protein Levels
- Improved Survival Rate in Digestive Conditions
- Improvement in Alcoholic Liver Disease
- Increased Degradation of Non-Assimilated Compounds
- Increased Dose Tolerance
- Increased Occurrence of Serious Adverse Events
- Increased Parabenzoylaminobenzoic Acid Concentration
- Increased Portal Endotoxin Levels
- Increased Serum Total Bile Acid Levels
- Increased Survival Rate of Alcohol-Treated Cells
- Increased Thermoplasma Abundance
- Maintained Albumin Levels
- Maintained Cell Viability in Low pH
- Maintained Normal ALT Levels
- Maintained Normal Liver Function
- Maintained pH Levels
- Modulated Metabolite Profile
- Prevention of Alcoholic Liver Disease
- Prolonged INR
- Reduced ALT Levels
- Reduced Acute Liver Injury
- Reduced Alcohol-Induced Liver Injury
- Reduced Ammonia Concentration
- Reduced Ammonia Excretion
- Reduced Ammonia Levels
- Reduced Ammonium Levels
- Reduced Aspartate Transaminase Activity
- Reduced Blood Ammonia Level
- Reduced Blood Ammonia Levels
- Reduced Blood Urea Nitrogen Levels
- Reduced Butyrylcholinesterase Activity
- Reduced Dimethyl Sulfide Level
- Reduced Encephalopathy
- Reduced Fecal Ammonia Levels
- Reduced Ferroptosis
- Reduced Fresh Frozen Plasma Transfusion
- Reduced GPT Level
- Reduced Gamma-Glutamyl Transferase Levels
- Reduced Gastrointestinal Microbial Fermentation-Related Intoxication
- Reduced Hepatotoxicity
- Reduced Incidence of Abnormal Increase in Alkaline Phosphatase
- Reduced Indoxyl Sulfate Levels
- Reduced Isoleucine Level
- Reduced Levels of Toxic Amines
- Reduced Liver Biochemical Markers
- Reduced Liver Damage Indicators
- Reduced Liver Disease Symptoms
- Reduced Liver Function
- Reduced Liver Function Indicators
- Reduced Liver Injury
- Reduced Liver Injury Indicators
- Reduced Liver Toxicity
- Reduced Microbial Translocation to the Liver
- Reduced Pathological Changes of Liver
- Reduced Plasma Ammonia Levels
- Reduced Plasma Urea Level
- Reduced Portal Vein LPS Levels
- Reduced Serpin Level
- Reduced Serum Alanine Aminotransferase Activity
- Reduced Serum Ammonia Levels
- Reduced Stool Ammonia Concentration
- Reduced Toxin-induced Cytotoxicity
- Reduced Urea Level
- Reduced Urinary p-Cresol Excretion
- Regulated Liver Metabolite Levels
- Stabilized Total Bilirubin Levels